These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2408970)

  • 1. (2'-5') oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease.
    Stalnikowicz R; Goder K; Karmeli F; Fiocchi C; Rachmilewitz D
    Gut; 1985 Jun; 26(6):556-61. PubMed ID: 2408970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon inhibits prostaglandin E2 synthesis and stimulates (2'-5')oligoadenylate synthetase activity in peripheral blood mononuclear cells of inflammatory bowel disease patients.
    Rachmilewitz D; Karmeli F; Panet A
    J Interferon Res; 1985; 5(4):629-35. PubMed ID: 2418132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (2'-5')Oligoadenylate synthetase activity in intestinal mononuclear and epithelial cells of inflammatory bowel disease patients.
    Rachmilewitz D; Stalnikowicz R; Karmeli F; Youngman K; Fiocchi C
    Scand J Gastroenterol; 1988 Oct; 23(8):941-7. PubMed ID: 3201131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligo-2',5'-adenylate synthetase activity in peripheral blood mononuclear leukocytes in various diseases.
    Fujii N; Kotake S; Hirose S; Ohno S; Yasuda I; Sagawa A; Ishikawa K; Minagawa T
    J Clin Microbiol; 1984 Dec; 20(6):1216-8. PubMed ID: 6520229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of serum 2-5AS activity and NK cell activity in the patients with Crohn's disease and ulcerative colitis].
    Suzuki H; Sata M; Yano Y; Kamoi S; Ikeda H; Sasaki E; Toyonaga A; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1988 Jan; 85(1):14-9. PubMed ID: 3373766
    [No Abstract]   [Full Text] [Related]  

  • 6. Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia.
    Schattner A; Wallach D; Merlin G; Hahn T; Levin S; Ramot B; Revel M
    J Interferon Res; 1982; 2(3):355-61. PubMed ID: 6182252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy.
    Fujii N; Oguma K; Fujii M; Fukatsu R; Takahata N; Kitabatake M
    Clin Exp Immunol; 1987 Apr; 68(1):168-76. PubMed ID: 2443283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
    Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
    Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of (2'-5') oligo-adenylate synthetase and interferon blood-levels in mice early after viral infection.
    Schattner A; Merlin G; Shapira A; Revel M; Wallach D
    J Interferon Res; 1982; 2(2):285-9. PubMed ID: 6181178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysozyme in plasma and neutrophilic granulocytes in ulcerative colitis and Crohn's disease.
    Koldkjaer O; Klitgaard NA; Schmidt KG
    Scand J Gastroenterol; 1977; 12(2):135-40. PubMed ID: 847381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells.
    Schattner A; Merlin G; Wallach D; Rosenberg H; Bino T; Hahn T; Levin S; Revel M
    J Interferon Res; 1981; 1(4):587-94. PubMed ID: 6180091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis.
    Letizia C; D'Ambrosio C; Agostini D; Corsi A; Boirivant M; Pallone F; Scavo D
    Ital J Gastroenterol; 1993 Jan; 25(1):23-5. PubMed ID: 8381313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells.
    Johnston MI; Preble OT; Imai J; Jacobsen H; Torrence PF
    J Immunol Methods; 1983 Dec; 65(1-2):123-35. PubMed ID: 6361140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
    Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
    Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of interferon levels with leukocyte (2'-5') oligoadenylate synthetase activity as markers of viral encephalopathies.
    Kennedy CR; Tilles JG
    J Interferon Res; 1988 Oct; 8(5):609-15. PubMed ID: 2466911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear leukocytes in Behçet's disease].
    Ohno S; Kotake S; Hirose S; Matsuda H; Fujii N
    Nippon Ganka Gakkai Zasshi; 1986 May; 90(5):771-4. PubMed ID: 2428227
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
    Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
    Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for the determination of the interferon-induced enzyme 2'-5' oligoadenylate synthetase in mononuclear blood cells.
    Bruchelt G; Beck J; Schilbach-Stückle K; Koscielniak E; Treuner J; Niethammer D
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):879-88. PubMed ID: 2450958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2',5'-Oligoadenylate synthetase and interferon in peripheral blood after rubella, measles, or mumps live virus vaccine.
    Tilles JG; Balkwill F; Davilla J
    Proc Soc Exp Biol Med; 1987 Oct; 186(1):70-4. PubMed ID: 3628253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission.
    Gionchetti P; Campieri M; Guarnieri C; Belluzzi A; Brignola C; Bertinelli E; Ferretti M; Miglioli M; Barbara L
    Dig Dis Sci; 1994 Mar; 39(3):550-4. PubMed ID: 8131691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.